When someone needs to stay on a psychiatric medication thats working for their mental health but is causing problematic weight gain, adding a low-dose GLP-1 might allow them to maintain their psychiatric stability while addressing the metabolic consequences
Comparison of pharmacokinetic parameters of a polypeptide, the BowmanBirk protease inhibitor (BBI), and its palmitic acid conjugate
Pushing through intolerable symptoms increases dropout risk and provides no benefit
Ozempic: What is the Difference
PLoS ONE 11(12):e0168396 Disclosures PB has acted as a consultant for Bayer, Bristol-Myers Squibb, Boehringer Ingelheim, Sanofi, Novo Nordisk and Horizon Pharma
It is welcome and wise to feel empowered to talk with a qualified healthcare professional, such as a registered dietitian